Active Biotech AB (publ) (LON:0GQU)

Active Biotech AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.4	36.22	41.8	53.13	26.21
Cash & Short-Term Investments	27.4	36.22	41.8	53.13	26.21
Cash Growth	-24.35%	-13.35%	-21.34%	102.70%	-56.08%
Accounts Receivable	-	-	-	-	0.28
Other Receivables	11.8	1.26	0.95	1.19	1.23
Receivables	11.8	1.26	0.95	1.19	1.51
Prepaid Expenses	-	1.24	1.38	1.53	1.5
Other Current Assets	-	-	-	-	1.06
Total Current Assets	39.2	38.71	44.12	55.86	30.28
Property, Plant & Equipment	3.4	4.72	6.26	0.95	1.87
Other Intangible Assets	0.2	0.25	0.25	-	-
Other Long-Term Assets	0.4	0.38	0.38	0	0
Total Assets	43.2	44.05	51.01	56.8	32.16
Accounts Payable	-	3.17	3.53	2.76	2.85
Accrued Expenses	-	5.36	6.37	5.98	4.75
Current Portion of Leases	-	1.55	1.61	0.76	1.31
Other Current Liabilities	8.9	0.3	0.56	0.41	0.44
Total Current Liabilities	8.9	10.38	12.06	9.9	9.35
Long-Term Leases	1.5	3	4.43	0.23	0.69
Other Long-Term Liabilities	0.1	-	-	-	-
Total Liabilities	10.5	13.38	16.49	10.13	10.04
Common Stock	32.7	1.87	1.37	1.13	0.75
Additional Paid-In Capital	-	3,472	3,431	3,386	3,312
Retained Earnings	-	-3,443	-3,398	-3,340	-3,291
Shareholders' Equity	32.7	30.67	34.51	46.67	22.11
Total Liabilities & Equity	43.2	44.05	51.01	56.8	32.16
Total Debt	1.5	4.55	6.04	0.99	2
Net Cash (Debt)	25.9	31.67	35.76	52.15	24.21
Net Cash Growth	-18.23%	-11.42%	-31.43%	115.38%	-57.09%
Net Cash Per Share	0.06	0.12	0.15	0.24	0.14
Filing Date Shares Outstanding	1,066	361.74	264.89	217.97	217.97
Total Common Shares Outstanding	1,066	361.74	264.89	217.97	145.24
Working Capital	30.3	28.33	32.06	45.95	20.93
Book Value Per Share	0.03	0.08	0.13	0.21	0.15
Tangible Book Value	32.5	30.42	34.27	46.67	22.11
Tangible Book Value Per Share	0.03	0.08	0.13	0.21	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.